Caitong International Asset Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$633 Buy
25
+4
+19% +$91 ﹤0.01% 1667
2026
Q1
$449 Sell
21
-1,016
-98% -$21.1K ﹤0.01% 1685
2025
Q4
$22.2K Buy
1,037
+1,031
+17,183% +$21.1K 0.01% 963
2025
Q3
$100 Sell
6
-1,188
-99% -$17.8K ﹤0.01% 1749
2025
Q2
$17.1K Buy
1,194
+1,038
+665% +$14.2K 0.01% 551
2025
Q1
$2.26K Buy
+156
New +$2.22K ﹤0.01% 1289

Other funds holding MD

Caitong International Asset Management's MD Position: Q2 2026 in Review

Caitong International Asset Management increased its Pediatrix Medical (MD) stake by 19% in Q2 2026, buying an estimated $91 and bringing the position to 25 shares worth $633. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

Caitong International Asset Management first reported a position in MD in Q1 2025 and has held it in 6 quarters since. The position peaked at $22.2K in Q4 2025. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Caitong International Asset Management held 25 shares of Pediatrix Medical worth $633 as of Q2 2026.
  • Caitong International Asset Management bought 4 Pediatrix Medical shares in Q2 2026, an estimated $91.
  • Pediatrix Medical made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1667 holding.
  • Caitong International Asset Management first reported a position in Pediatrix Medical in Q1 2025 and has held it in 6 quarters since.
  • Caitong International Asset Management's Pediatrix Medical position peaked at $22.2K in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.